Edesa Biotech (EDSA) Live Share Price, Invest From India

Edesa Biotech Stock Performance

as on September 2, 2026 at 2:15 pm IST

Day's Low
Day's High
$4.61
Day's Price Range
$4.96
$4.78
3.56%
Downside
3.77%
Upside
52 Week's Low
52 Week's High
$0.72
52-Week Price Range
$20.32
$4.78
84.94%
Downside
325.10%
Upside

Edesa Biotech share price movements today

Previous Close: $4.74
Open: $4.75
Volume: 163.0K
Market Cap: $44.5M
Day's Low - High: $4.61 - $4.96
52 Week Low - High: $0.72 - $20.32

Edesa Biotech Historical Returns

1 Month Return: -9.59 %
3 Month Return: -36.01 %
1 Year Return: + 99.14 %
3 Year Return: -22.08 %
5 Year Return: -88.76 %

Edesa Biotech Stock Fundamentals & Key Indicators

Check Edesa Biotech market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$44.5M

EPS (TTM)

-1.9867

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-14.5M

Revenue (TTM)

500.0

Profit Margin

0.00%

Return On Equity TTM

-122.93%

Edesa Biotech vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Edesa Biotech with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Edesa Biotech	BUY	$44.5M	-88.76%	NA	0.00%	NA
Revolution Medicines	BUY	$44.6B	614.61%	NA	0.00%	NA
Vertex Pharmaceuticals	BUY	$137.2B	170.45%	31.92	86.04%	NA
Moderna	BUY	$55.1B	-63.37%	-7.98	-12.57%	NA
Regeneron	BUY	$85.8B	17.94%	19.9	84.86%	0.44%

Stock Returns calculator for Edesa Biotech Stock including INR - Dollar returns

The Edesa Biotech stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Edesa Biotech investment value today

Current value as on today

₹2,22,281

Returns

₹1,22,281

(+122.28%)

Returns from Edesa Biotech Stock

₹1,06,034 (+106.03%)

Dollar Impact

₹16,246 (+16.25%)

Analyst Recommendation on Edesa Biotech Stock

Based on 1 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 1 analysts, 100% of analysts recommend a 'BUY' rating for Edesa Biotech. Average target price of $16.33

Edesa Biotech Share Price Target

Get share price movements and forecasts by analysts on Edesa Biotech.

What analysts predicted

70.73%UPSIDE

Target Price

$16.33

Current Price

$4.78

Analyzed by

1 Analysts

Target

$16.33

Edesa Biotech target price $16.33, a slight upside of 70.73% compared to current price of $4.78. According to 1 analysts rating.

Indian Investors' Interest in Edesa Biotech Stock

Search interest for Edesa Biotech Stock has increased by 13% in the last 30 days, reflecting an upward trend in search activity.

Time period: August 3, 2026 to September 2, 2026

Change:13% versus previous 30 day period

Edesa Biotech Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	-	-	-	-	-	-	-	-	0
Gross Profit	0	0	0	0	0	0	0	0	0
Operating Income	-2	-1	-1	-1	-1	-1	-2	-2	-4
EBITDA	-1	-1	0	-1	-1	-1	-2	-2	-4
Interest Expense	-	-	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0
Income Before Tax	-1	-1	0	-1	-1	-1	-2	-2	-4
Income Tax Expense	0	0	-	-	0	-	-	-	0
Net Income	-1	-1	0	-1	-1	-1	-2	-2	-4
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-8284.56%

Edesa Biotech Annual Profit & Loss

All numbers in Millions USD

	Sep 2016	Sep 2017	Sep 2018	Sep 2019	Sep 2020	Sep 2021	Sep 2022	Sep 2023	Sep 2024	Sep 2025
Total Revenue	1	0	0	0	0	0	-	-	-	-
Gross Profit	0	0	0	0	0	0	0	0	0	0
Operating Income	-4	-5	-5	-2	-6	-23	-18	-9	-7	-7
EBITDA	-4	-4	-4	-2	-6	-13	-17	-9	-6	-7
Interest Expense	-	-	-	0	0	0	0	-	-	-
Depreciation	-	0	0	0	0	0	0	0	0	0
Income Before Tax	-5	-5	-5	-2	-6	-13	-17	-8	-6	-7
Income Tax Expense	0	0	0	0	0	0	0	0	0	0
Net Income	-5	-5	-5	-2	-6	-13	-17	-8	-6	-7
Net Profit Margin	-395.23%	-2203.65%	-2378.56%	-662.33%	-1935.59%	-2668630.00%	0.00%	0.00%	0.00%	0.00%

Edesa Biotech Quarterly Cash Flow

All numbers in Millions USD

	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Net Income	-1	0	-1	-1	-1	-2	-1	-4	-6
Operating Cash Flow	0	0	-1	-2	-1	-1	-2	-2	-3
Investing Cash Flow	-	-	-	-	-	-	-	-	-
Financing Cash Flow	0	0	2	14	0	0	3	0	3
Change in Cash	0	-1	0	12	-1	-1	1	-2	0

Edesa Biotech Annual Cash Flow

All numbers in Millions USD

	Sep 2017	Sep 2018	Sep 2019	Sep 2020	Sep 2021	Sep 2022	Sep 2023	Sep 2024	Sep 2025
Net Income	-5	-5	-2	-6	-13	-17	-8	-6	-7
Operating Cash Flow	-4	-4	-4	-4	-13	-12	-6	-4	-7
Investing Cash Flow	1	-4	6	0	0	0	-	-	-
Financing Cash Flow	0	8	7	7	14	11	4	0	17
Change in Cash	-2	0	1	2	0	0	-1	-4	9

Mutual Funds that own Edesa Biotech Stock

Check out the Mutual Funds with significant holdings in Edesa Biotech.

Funds	Holdings	Shares Held
VANGUARD INDEX FUNDS	0.891668%	85966
Fidelity Concord Street Trust	0.406076%	39150

Global Institutional Holdings in Edesa Biotech

Funds	Holdings
Joseph Edelman	5.84%
Vanguard	0.85%

Insights on Edesa Biotech

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 6 months, EDSA stock has moved up by 107.7%
NO EFFECT
Against Peers
In the last 3 years, Revolution Medicines, Inc. Common Stock has given 24.7% return, outperforming this stock by 43.9%
NO EFFECT
Against Peers
In the last 1 year, Moderna, Inc. Common Stock has given 480.2% return, outperforming this stock by 377.9%

About Edesa Biotech

Edesa Biotech, Inc., a clinical-stage biopharmaceutical company, engages in the research and development, manufacture, and commercialization of pharmaceutical products for inflammatory and immune-related diseases. It develops EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress syndrome; and EB01, a topical vanishing cream containing non-steroidal anti-inflammatory compound that has completed Phase 3 clinical study to treat chronic allergic contact dermatitis. The company develops EB07, a monoclonal antibody, which is in a Phase 2 clinical study for the treatment of pulmonary fibrosis; and EB06, a human monoclonal antibody candidate that binds to chemokine ligand 10 (CXCL10) and inhibits the interaction of CXCL10 with its receptors, CXCR3A, and CXCR3B. It has a collaboration agreement with NovImmune SA to develop monoclonal antibodies targeting products containing toll-like receptor 4 and CXCL10 for therapeutic, prophylactic, and diagnostic applications in humans and animals; and Yissum Research Development Company for the development of products for therapeutic, prophylactic, and diagnostic uses in topical dermal and anorectal applications, as well as for the use in dermatologic and gastrointestinal conditions. The company was founded in 2015 and is headquartered in Markham, Canada.

Organisation	Edesa Biotech
Headquarters	100 Spy Court, Markham, ON, Canada, L3R 5H6
Industry	Biotechnology
CEO	Dr. Pardeep Nijhawan FRCPC, M.D.
E-voting on shares	Click here to vote

Key Management of Edesa Biotech

Name	Title
Dr. Pardeep Nijhawan FRCPC, M.D.	CEO, Company Secretary & Director
Dr. Michael J. Brooks M.B.A., Ph.D.	President
Mr. Peter John Weiler M.B.A, M.Sc.	Chief Financial Officer

FAQs

What is Edesa Biotech share price today?

Edesa Biotech share price today is $4.78 as on September 2, 2026 at 8:45 am IST at the close of the market. Edesa Biotech share today touched a day high of $4.96 and a low of $4.61.

What is the 52 week high and 52 week low for Edesa Biotech share?

Edesa Biotech share touched a 52 week high of $20.32 on May 1, 2026 and a 52 week low of $0.72 on February 20, 2026. Edesa Biotech stock price today i.e. September 2, 2026 at 8:45 am IST is closed at $4.78,which is 76.48% down from its 52 week high and 563.89% up from its 52 week low.

What is Edesa Biotech's market capitalisation today?

Edesa Biotech market capitalisation is $0.00T as on September 2, 2026 at 8:45 am IST.

How to invest in Edesa Biotech Stock (EDSA) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Edesa Biotech on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Edesa Biotech Shares that will get you 0.3138 shares as per Edesa Biotech share price of $4.78 per share as on September 2, 2026 at 8:45 am IST.

What is the minimum amount required to buy Edesa Biotech Stock (EDSA) from India?

Indian investors can start investing in Edesa Biotech (EDSA) shares with as little as ₹94.94 or $1 (as of September 2, 2026 at 8:56 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹949.40 in Edesa Biotech stock (as per the Rupee-Dollar exchange rate as on September 2, 2026 at 8:56 am IST). Based on Edesa Biotech share’s latest price of $4.78 as on September 2, 2026 at 8:45 am IST, you will get 2.0921 shares of Edesa Biotech. Learn more about fractional shares .

What are the returns that Edesa Biotech has given to Indian investors in the last 5 years?

Edesa Biotech stock has given -88.76% share price returns and 30.37% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?